Benchmark Maintains Buy on MaxLinear, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst David Williams maintains a Buy rating on MaxLinear (NASDAQ:MXL) and raises the price target from $23 to $28.

April 15, 2024 | 2:52 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst David Williams maintains a Buy rating on MaxLinear and raises the price target from $23 to $28.
The increase in price target by Benchmark analyst David Williams from $23 to $28 reflects a positive outlook on MaxLinear's stock, suggesting a bullish sentiment that could lead to a short-term increase in the stock price. The Buy rating reaffirmation further supports this positive sentiment.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100